Biotricity Inc

General ticker "BTCY" information:

  • Sector: Health Care
  • Industry: Health Care Technology
  • Capitalization: $6.5M

Biotricity Inc does not follow the US Stock Market performance with the rate: -42.6%.

Estimated limits based on current volatility of 8.7%: low 0.24$, high 0.29$

Factors to consider:

  • Current price 61.2% below estimated low
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-03-31 to 2026-03-31

  • 2024-03-31 to 2025-03-31 estimated range: [0.63$, 3.44$]
  • 2025-03-31 to 2026-03-31 estimated range: [0.95$, 4.44$]

Financial Metrics affecting the BTCY estimates:

  • Negative: Non-GAAP EPS, $ of -1.32 <= 0.10
  • Negative: Operating profit margin, % of -42.26 <= 1.03
  • Negative: Operating cash flow per share per price, % of -37.63 <= 2.35
  • Negative: Inventory ratio change, % of 6.31 > 1.08
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -6.16 <= 1.31

Similar symbols

Short-term BTCY quotes

Long-term BTCY plot with estimates

Financial data

YTD 2022-03-31 2023-03-31 2024-03-31
Operating Revenue $7.65MM $9.64MM $12.06MM
Operating Expenses $24.39MM $25.05MM $20.89MM
Operating Income $-16.74MM $-15.41MM $-8.83MM
Non-Operating Income $-12.39MM $-3.25MM $-5.27MM
Interest Expense $10.57MM $2.58MM $5.19MM
R&D Expense $2.74MM $3.23MM $2.57MM
Income(Loss) $-29.13MM $-18.66MM $-14.09MM
Profit(Loss) $-29.13MM $-18.66MM $-14.09MM
Stockholders Equity $-2.14MM $-19.85MM $-29.98MM
Inventory $0.84MM $2.34MM $1.88MM
Assets $16.68MM $6.51MM $5.94MM
Operating Cash Flow $-15.16MM $-13.55MM $-6.69MM
Capital expenditure $0.03MM $0.00MM $0.00MM
Investing Cash Flow $-0.03MM $0.00MM $0.00MM
Financing Cash Flow $25.17MM $2.00MM $6.74MM
Earnings Per Share* $-3.85 $-2.15 $-1.66

* EPS are Split Adjusted, recent splits may be reflected with a delay.